Sleep Apnea News and Research

RSS

Breathe Technologies earns Medical Design Excellence Award for NIOV System

Breathe Technologies, Inc. today announced that their Non-Invasive Open Ventilation (NIOV) System has been awarded a prestigious Medical Design Excellence Award (MDEA).

30 May 2012

Severity of nocturnal hypoxemia and SDB independently predict both T2DM and HbA1c levels

The severity of sleep disordered breathing and nocturnal hypoxemia independently predict both glycosylated hemoglobin (HbA1c) levels and type 2 diabetes mellitus (T2DM), according to a new study.

24 May 2012

Study confirms links between metabolic dysregulation, SDB and obesity

Weight loss improved both metabolic parameters and sleep-disordered breathing (SDB) in obese children in a new study from researchers in Belgium, confirming links between metabolic dysregulation, SDB and obesity.

24 May 2012

Omron introduces new wireless sleep monitoring device

ResMed Inc. today announced the launch of the first product in Japan using technology from its recently acquired company, BiancaMed. The product, launched by BiancaMed partner Omron Healthcare, is a new wireless sleep monitoring device.

From ResMed Corp 24 May 2012

Studies examine effectiveness of CPAP in reducing risk of cardiovascular outcomes linked with OSA

Two studies that included adults with obstructive sleep apnea examined the effectiveness of reducing the risk of cardiovascular outcomes, including high blood pressure, by treatment with continuous positive airway pressure (CPAP), according to the articles in the May 23/30 issue of JAMA.

23 May 2012

Children with craniofacial disorders face numerous medical challenges beyond appearance

Children born with cleft lip, cleft palate and other craniofacial disorders face numerous medical challenges beyond appearance.

23 May 2012

SDB may increase risk of cancer mortality

Sleep-disordered breathing (SDB) is associated with an increased risk of cardiovascular, metabolic and neurocognitive disorders. New studies show that it also implies a greater risk of developing tumors, and even dying from cancer.

22 May 2012

SERVE-HF study on effect of CSA treatment for stable heart failure enrolls 1,000th participant

SERVE-HF, the largest study to investigate if treatment of predominant central sleep apnea (CSA) improves survival and outcomes of patients with stable heart failure, has enrolled its 1,000th participant. The study, sponsored by ResMed Ltd., is the largest of its kind. This milestone brings the SERVE-HF study, which began in 2008, one step closer to its target of approximately 1,250 participants.

From ResMed Corp 21 May 2012

Primary care-based management can reduce burden of OSA

Patients with moderate-to-severe obstructive sleep apnea (OSA) can be successfully managed in a primary care setting by appropriately trained primary care physicians (PCPs) and community-based nurses, according to Australian researchers.

21 May 2012

Treatment of OSA in children can reverse neuronal brain injury

Treatment of obstructive sleep apnea (OSA) in children normalizes disturbances in the neuronal network responsible for attention and executive function, according to a new study.

21 May 2012

Sleep-disordered breathing may increase risk of cancer mortality

Sleep-disordered breathing (SDB), commonly known as sleep apnea, is associated with an increased risk of cancer mortality, according to a new study.

21 May 2012

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA ER (tapentadol) extended-release tablets were significantly more effective than placebo in providing pain management among adults with chronic moderate to severe, painful diabetic peripheral neuropathy.

18 May 2012

Galleon GAL-021 safe and well-tolerated in Phase I respiratory depression clinical study

Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.

7 May 2012

Regular jogging increases life expectancy

Undertaking regular jogging increases the life expectancy of men by 6.2 years and women by 5.6 years, reveals the latest data from the Copenhagen City Heart study presented at the EuroPRevent2012 meeting.

4 May 2012

Excessive daytime sleepiness may cause learning, attention and behavior problems

Children who have learning, attention and behavior problems may be suffering from excessive daytime sleepiness, even though clinical tests show them sleeping long enough at night, a new study reports.

2 May 2012

HealthClips Rx patient education app now available in iTunes

Milner-Fenwick, Inc. and Preventice, Inc. announced today that the HealthClips Rx patient education app is now available in iTunes. To familiarize health care providers with this interactive patient education model, Milner-Fenwick and Preventice are offering a free, two-week trial to physicians and care providers.

2 May 2012

Teva, Mylan settle patent infringement litigation for Nuvigil

Teva Pharmaceutical Industries Ltd., one of the world's largest producers of pharmaceuticals, announces that it has settled patent infringement litigation regarding U.S. Patent Number 7,132,570 (the "'570 patent") with respect to Mylan Inc.'s ANDA for Teva's wakefulness product NUVIGIL (armodafinil) tablets.

30 Apr 2012

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.

30 Apr 2012

Enrollment complete for In-tunnel SeptRx European PFO Trial in Europe

SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.

23 Apr 2012

A guide to catch and treat hypertension early in children

High blood pressure in children and adolescents is a growing health problem that is often overlooked by physicians, according to a University of Michigan Health System article published in American Family Physician that offers doctors a guide to catching and treating hypertension early.

18 Apr 2012

Sleep Apnea News and Research

Breathe Technologies earns Medical Design Excellence Award for NIOV System

Severity of nocturnal hypoxemia and SDB independently predict both T2DM and HbA1c levels

Study confirms links between metabolic dysregulation, SDB and obesity

Omron introduces new wireless sleep monitoring device

Studies examine effectiveness of CPAP in reducing risk of cardiovascular outcomes linked with OSA

Children with craniofacial disorders face numerous medical challenges beyond appearance

SDB may increase risk of cancer mortality

SERVE-HF study on effect of CSA treatment for stable heart failure enrolls 1,000th participant

Primary care-based management can reduce burden of OSA

Treatment of OSA in children can reverse neuronal brain injury

Sleep-disordered breathing may increase risk of cancer mortality

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Galleon GAL-021 safe and well-tolerated in Phase I respiratory depression clinical study

Regular jogging increases life expectancy

Excessive daytime sleepiness may cause learning, attention and behavior problems

HealthClips Rx patient education app now available in iTunes

Teva, Mylan settle patent infringement litigation for Nuvigil

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

Enrollment complete for In-tunnel SeptRx European PFO Trial in Europe

A guide to catch and treat hypertension early in children

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News